Skip to content

Search for:

Contact

US/CA

UK

Test Guide
- United States
- Canada
Diagnostics
Sound Imaging
AIS
Resources
About
Antech Online

Media Hub

Media Hub
Podcast
Blog
Case Studies
Webinars
News
Events
Collaborations

Archives: Events

Events

AAEP 2024

Posted On

Published: November 12, 2024

Events

ACVP 2024

Posted On

Published: June 21, 2024

Events

Fetch Long Beach 2024

Posted On

Published: June 20, 2024

Follow us on Instagram

antech_diagnostics

Your 2025 Antech Directory of Services is going pa

Your 2025 Antech Directory of Services is going paperless!

By going fully digital, you’ll be able to quickly access the up-to-date information you need—anytime, anywhere.

The digital 2025 Antech Directory of Services will arrive in your inbox before the end of the year!

The American Veterinary Medical Association estima

The American Veterinary Medical Association estimates that approximately half of dogs aged 10 and older will develop cancer.1

Fast, convenient tools with rapid results are crucial for managing neoplasia, and with Nu.Q® on the Element i+™, you can inform owners of their pet’s risk for certain canine cancers in a matter of minutes during senior patient wellness exams.*

Nu.Q® on the Element i+ is the industry's only in-house canine cancer screening blood test to assess the risk for certain diseases, including lymphoma and hemangiosarcoma.

Indicated for all dogs aged 7 and older, Nu.Q® on the Element i+ enables you to give pet owners vital information while the patient is still in the exam room.

👉Tap the link in bio to discover how Nu.Q® on the Element i+ can help you get (and give) more from senior wellness visits.

*Nu.Q®️ is not a confirmatory test for cancer. Nu.Q®️ results should act as an impetus to perform additional diagnostics to obtain a diagnosis. Elevated plasma nucleosome concentration does not tell you which cancer is present, and further diagnostics will be needed. Certain inflammatory conditions may increase plasma nucleosome concentration and in these instances Nu.Q® cannot differentiate between cancer and an inflammatory response.

Nu.Q® is a registered trademark of VolitionRx Limited and its subsidiaries. The Nu.Q® Canine Cancer Test is supplied to Antech’s Heska affiliate under license by Belgian Volition SRL.

1. Cancer in Pets. American Veterinary Medical Association. (2022). Retrieved 9 July 2022, from https://www.avma.org/resources/pet-owners/petcare/cancer-pets

The speed of Artificial Intelligence. The experti

The speed of Artificial Intelligence.

The expertise of leading veterinary radiologists and data scientists.

That’s AIS RapidRead™️.

Click the link in our bio to learn more.

This number becomes even more sobering when you co

This number becomes even more sobering when you consider how many dogs won’t receive a cancer diagnosis this year –– but should.

That’s why Antech offers innovative canine cancer detection and screening options that are both accurate and accessible:

🐶 Nu.Q® on the Element i+™ is the industry's only in-house canine cancer screening blood test to determine the current likelihood of certain diseases, including lymphoma and hemangiosarcoma, helping you refine your differential diagnosis list in minutes.*
🐶 CADET™ BRAF identifies ~85% of transitional cell carcinoma/urothelial carcinoma (TCC/UC) cases by evaluating free-catch urine samples from dogs for the presence of cells harboring the BRAF mutation.
🐶 CADET™ BRAF-PLUS provides further evaluation of dogs with clinical signs, but for whom no BRAF mutation is detected, and finds approximately 2/3 of the TCC/UC cases not identified by CADET BRAF.

👉Tap the link in bio to explore these cancer detection tests in more detail.

*Nu.Q®️ is not a confirmatory test for cancer. Nu.Q®️ results should act as an impetus to perform additional diagnostics to obtain a diagnosis. Elevated plasma nucleosome concentration does not tell you which cancer is present, and further diagnostics will be needed. Certain inflammatory conditions may increase plasma nucleosome concentration and in these instances Nu.Q® cannot differentiate between cancer and an inflammatory response.

Nu.Q® is a registered trademark of VolitionRx Limited and its subsidiaries. The Nu.Q® Canine Cancer Test is supplied to Antech’s Heska affiliate under license by Belgian Volition SRL.

1. National Cancer Institute: https://ccr.cancer.gov/comparative-oncology-program/about

Site Footer

To start of page

Better diagnostics.
Better medicine.

Sign up today to get Media Hub updates

Email(Required)
Phone
This field is for validation purposes and should be left unchanged.

Antech USA: 1-800-872-1001

Antech Canada: 1-800-341-3440

Antech UK: +44 8082 583536

Billing: 1-800-872-1001; Email

About
Cookie Policy
Contact Us
Privacy Policy
Terms and Conditions
Terms of Use
Supplier Terms & Conditions
Product SDS Forms
Web Accessibility
Ad Choices

Your Privacy Choices

Visit our Facebook page
Visit our Instagram page
Visit our Podcast page
Visit our Linkedin page

©2024 Antech Diagnostics, Inc. All rights reserved.

×